ORDER GRANTING DEFENDANT’S MOTIONS TO DISMISS
This matter is before the Court on defendant Merrell-Dow Pharmaceuticals, Inc’s., (hereinafter Merrell-Dow) renewed Motions to Dismiss the above-captioned complaints based on the doctrine of forum non conveniens. Plaintiffs filed a memorandum contra the original Motions.
*1132 I. Introduction
Plaintiffs in the cases addressed herein are all residents of the United Kingdom. These suits were originally filed in the Southern District of New York against Richardson-Merrell, Inc., the predecessor of defendant Merrell-Dow, based on diversity of citizenship. In their complaints, plaintiffs alleged that they were injured as a result of their mothers’ ingestion of the drug Debendox during pregnancy, and that defendant is liable to them based on its conduct in the development, marketing, testing, and promotion of Debendox as well as the related drug Bendectin. 1 Debendox is manufactured and distributed in the United Kingdom by Richardson-Merrell Ltd., a wholly-owned British subsidiary of the defendant. Richardson-Merrell Ltd. was not named as a defendant in these actions.
The motions at issue herein were originally filed in the Southern District of New York. After oral argument on the motion, but prior to the Court’s ruling, plaintiffs moved to voluntarily dismiss these actions pursuant to Rule 41(a)(2), or, in the alternative, to transfer these actions to the Southern District of Ohio. In his Memorandum and Order of February 1, 1982, as modified by a subsequent Memorandum and Order of February 25, 1982, Judge Brieant ordered that these cases be transferred to this Court pursuant to 28 U.S.C. § 1404(a). Defendant has since renewed its pending motion to dismiss these cases based on the doctrine of forum non conveniens.
An initial question raised by defendant’s motion is whether federal or state law controls the application of the doctrine of
forum non conveniens
in these cases. This issue once again eludes decision, however, because New York courts appear to follow the same standards set forth in the federal cases.
2
Gulf Oil Corp. v. Gilbert,
II. The Doctrine of Forum Non Conveniens
In
Gulf Oil Corp. v. Gilbert,
In
Piper Aircraft Co. v.
Reyno,-U.S. -,
The Supreme Court in
Reyno
first held that the fact that Scottish law was less favorable to plaintiffs did not render a dismissal based on
forum non conveniens
inappropriate, and that “[t]he possibility of a change in substantive law should ordinarily not be given conclusive or even substantial weight in the
forum non conveniens
inquiry.”
Id.
at-,
The Supreme Court also held that the presumption in favor of a plaintiff’s choice of forum is of less force when the plaintiff is foreign because the underlying assumption that such choice is one of convenience is absent.
Id.
at -,
Application of the Doctrine of Forum Non Conveniens to These Cases
A prerequisite to dismissal of a case on the grounds of
forum non conveniens,
is the availability of an alternative forum.
Gulf Oil Corp.
v.
Gilbert,
In response to plaintiffs’ concerns, we note that courts have frequently conditioned a dismissal on the grounds of
forum non conveniens
upon defendant’s consent to jurisdiction in the alternative forum.
Rey-no v. Piper Aircraft Co.,
In its Motion to Dismiss, defendant argues that the following “private interest” factors favor trial of these actions in the United Kingdom. First, defendant contends that the availability of witnesses and sources of proof render the United Kingdom a more convenient forum. Specifically, defendant cites the testimony and records of plaintiffs’ treating physicians, the testimony and records of employees of both Richardson-Merrell Ltd., and Boots Pure Drug Co., Ltd., the manufacturer of Deben-dox, the location of records of British regulatory authorities and witnesses related thereto, the location of records revealing plaintiffs’ and their parents’ genetic and health histories, and finally, the fact that potential witnesses in the United Kingdom who are not parties to this action would not be subject to compulsory process. The defendant also contends that there is a risk that a judgment in defendant’s favor in this Court would not be afforded comity in the United Kingdom.
Although plaintiffs have not responded in this Court to defendant’s renewal of its Motions to Dismiss, we anticipate the following “private interest factors” in favor of trial in this district. 4 Many, if not all of defendant’s employees and records are now present in this district. 5 Defendant has also been sued by numerous plaintiffs who are residents of this country based on its sales of the related drug Bendectin. A total of 118 of these cases are now consolidated before this Court for pretrial purposes pursuant to an Order of the Multi-District Litigation Panel.
The Court notes the somewhat anomalous positions from which the parties argue convenience. Although parties customarily urge an alternative forum based on their own convenience, defendant Merrell-Dow, whose corporate headquarters are located in Cincinnati, Ohio, nevertheless asserts that it is more convenient to try this case in Great Britain. Plaintiffs, on the other hand, despite their residence in the United Kingdom, would undoubtedly argue that Cincinnati is the more appropriate forum. As the Supreme Court conceded in
Reyno,
the private interest factors in these cases “point in both directions.” - U.S. at -,
While defendant’s records and files are now located in Ohio, the location of this type of evidence does not bear heavily on the convenience of trial in a particular forum. Nor can plaintiffs assert that this Court is a preferred forum because Ameri-
*1135
can courts provide greater access to such sources of proof. The Supreme Court in
Reyno
specifically stated that in such eases “district courts might dismiss subject to the condition that defendant corporations agree to provide the records relevant to the plaintiff’s claims.” -U.S. at-,
On the other hand, that evidence, including witnesses, which addresses the plaintiff’s injuries and the specific manufacture and sale of the Debendox ingested by plaintiffs’ mothers is all located in Great Britain. As Judge Weinman noted in the Harrison case, supra:
“Moreover, if some marketing decisions were indeed made in Pennsylvania, evidence as to their nature and effect constitutes but a part of the total case which plaintiffs must present to the trier of fact in order to sustain their burden of proof. There can be no finding of liability without a showing of injury. Whether or not tortious decisions were made or controlled by defendant in Pennsylvania, all manufacture, marketing, prescription, sale and ingestion of the drugs occurred in the United Kingdom, as did, most importantly, the resulting injuries and deaths. Thus, even if all evidence relevant to the issue of nature and situs of the alleged tort is to be found in Pennsylvania, all other necessary evidence as to the elements required to establish liability will be found in the United Kingdom.”
The more impressive arguments in favor of dismissal of these eases address the “public interest” factors which are involved in the forum non conveniens inquiry. Defendant argues that to allow these foreign plaintiffs access to American courts on the bare nexus that a product was developed and tested in this country, when it was manufactured and sold abroad by a foreign corporation, would flood this country with cases in which its own interest is minimal and the United Kingdom’s great. We find this argument highly persuasive from both a practical and theoretical viewpoint.
One of the public interest factors which the Court may consider in a
forum non conveniens
inquiry is whether it will be necessary to apply foreign law. Because this case was transferred to this Court pursuant to 28 U.S.C. § 1404(a), we must apply the same substantive law and choice of law rules which would have governed the trans-feror court.
Van Dusen v. Barrack,
In
Babcock v. Johnson,
Consistent with the New York choice of law inquiry, we find that from a theoretical or policy perspective, the United Kingdom is the more appropriate forum for trial of the issues raised herein. As the Court in Harrison stated:
“Questions as to the safety of drugs marketed in a foreign country are properly the concern of that country; the courts of the United States are ill-equipped to set a standard of product safety for drugs sold in other countries. The issues raised here concern the knowledge, if any, of an allegedly unreasonable risk, and the sufficiency of the warning of that risk to users of the product. Both the British and the American governments have established requirements as to the standards of safety for drugs and the adequacy of any warnings to be given in connection with its use. Each government must weigh the merits of permitting the drug’s use and the necessity of requiring a warning. Each makes its own determination as to the standards of degree of safety and duty of care. This balancing of the overall benefits to be derived from a product’s use with the risk of harm associated with that use is peculiarly suited to a forum of the country in which the product is to be used.”510 F.Supp. at 4 .
The Court may also take into consideration its own administrative concerns, and the fairness of burdening a jury in this district with a trial in which this country’s interest is less than compelling. Because of the pending multi-district litigation, it is true that cases would not have an adverse effect on the Court’s docket insofar as pretrial discovery is concerned. Because they were transferred pursuant to 1404(a), however, trial to a jury of each of these actions in this district would be required. We also cannot ignore the likelihood that countless additional actions against the defendant by foreign plaintiffs will be filed in this district or transferred to it, absent the Court’s dismissal of these actions. The minimal nexus this jurisdiction has with such cases simply does not justify the potential burden on this Court and the citizens of this district.
This Court is aware that Judge Battisti of the Northern District of Ohio has recently denied a Motion to Dismiss based on similar grounds in five Bendectin cases pending before that Court.
Lake v. Richardson-Merrell, Inc.,
When the public interest factors identified above are considered with the private interest factors, the scale tips heavily towards dismissal of these actions. The fact that the multi-district litigation involving Bendectin is now before this Court is not of sufficient weight to affect that assessment. Accordingly, for the reasons stated herein, the Court finds that these actions should be *1137 dismissed. Such dismissal is conditioned upon the following:
(1) defendant’s consent to suit and acceptance of process in the United Kingdom in any civil actions filed by plaintiffs on their claims;
(2) defendant’s agreement to make available any documents or witnesses within its control that are necessary for fair adjudication of any action brought in the United Kingdom by the plaintiffs on their claims;
(3) defendant’s consent to pay any judgment or judgments which may be rendered against it in the United Kingdom in any civil action brought by plaintiffs on their claims; and
(4) defendant’s agreement to waive any statute of limitations defense that did not exist prior to the institution of any of these actions.
IT IS SO ORDERED.
Notes
. Bendectin is a prescription drug which defendant manufactures in the United States. Debendox is a similar, if not identical, drug which is manufactured and sold in the United Kingdom.
. The Supreme Court continues to reserve this question.
Piper
Aircraft Co.
v.
Reyno,-U.S. -, - n.13,
. As Judge Brieant noted in his Memorandum and Order of February 25, 1982:
“Most of the ‘public interest factors’ affecting the convenience of the forum relate peculiarly to the court in which the case is pending, rather than to the state in which the federal court is located.” (emphasis in original).
. Plaintiffs argued in their memorandum filed in the Southern District of New York that New York was a convenient forum for these cases.
. Defendant’s corporate headquarters were moved from Wilton, Connecticut to Cincinnati, Ohio on March 10, 1981.
. In Reyno, which involved an American manufacturer, the Supreme Court noted:
“Respondent argues that American citizens have an interest in insuring that American manufacturers are deterred from producing defective products, and that additional deterrents might be obtained if Piper and Hartzell were tried in the United States where they could be sued on the basis of both negligence and strict liability. However, the incremen *1136 tal deterrents that would be gained if this trial were held in an American court is likely to be insignificant.” -U.S. at-,102 S.Ct. at 268 .
